IBIO

Value 202020212022202320242025 TTM Total revenue 2.37 M2.38 M0225 K400 K100 K 100 K Gross profit 909 K2.17 M0225 K400 K100 K 100 K Operating expenses 32.02 M51.86 M29.34 M16.86 M19 M35.24 M 35.24 M Selling/general/admin expenses 22.03 M34.13 M19.02 M11.67 M10.69 M10.6 M 10.6 M Research & development 9.99 M17.73 M10.33 M5.18 M8.31 M19.64 M 19.64 M Operating income -31.11 M-49.69 M-29.34 M-16.63 M-18.6 M-35.14 M -35.14 M Non-Operating Income, Total 7.9 M-614 K32 K1.19 M225 K2.1 M 2.1 M Interest expense, net of interest capitalized 2.45 M1.41 M83 K172 K212 K53 K 53 K Non-Operating Income, excl. Interest Expenses 5.44 M-2.03 M-51 K1.19 M225 K2.1 M 2.1 M Unusual income/expense —6 000———— — Pretax income -28.11 M-51.43 M-29.43 M-14.81 M-18.59 M-33.04 M -33.1 M Equity in earnings —————— — Taxes 000000 0 Non-controlling/minority interest -6 000-1 000———— — After tax other income/expense —————— — Net income before discontinued operations -23.21 M-50.3 M-29.31 M-15.44 M-8.91 M-33.04 M -33.04 M Discontinued operations ——-35.7 M-9.46 M-9.46 M— — Net income -23.21 M-50.3 M-65.01 M-24.91 M-18.38 M-33.04 M -33.04 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -23.47 M-50.39 M-29.31 M-24.91 M-18.38 M-33.04 M -33.04 M Basic earnings per share (Basic EPS) —-115.6-106.2-6.5-1.75-0.32 -0.32 Diluted earnings per share (Diluted EPS) —-115.6-106.2-6.5-1.75-0.32 -0.32 Average basic shares outstanding —436.05 K612.25 K3.83 M10.5 M104.06 M — Diluted shares outstanding —436.05 K612.25 K3.83 M10.5 M104.06 M — EBITDA -28.48 M-46.1 M-28.25 M-15.59 M-17.83 M-34.69 M -25.52 M EBIT -31.11 M-49.69 M-29.34 M-16.63 M-18.6 M-35.14 M -35.14 M Cost of revenue 1.46 M216 K———— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 2.63 M3.59 M1.09 M1.05 M775 K452 K 9.62 M